1. Japan Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
CYBERDYNE Inc.

CYBERDYNE Inc.

CYBQF
CYBERDYNE Inc.US flagOther OTC
1.87
USD
- -
- -
248.85MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
2.62
3.27
6.22
7.76
8.04
7.95
8.33
8.72
9.99
15.32
20.62
20.74
10.44
Basic EPS, GAAP
-3.95
-4.74
-3.53
-3.16
-3.13
-2.94
-0.71
-0.27
-2.31
-1.39
-6.99
-2.73
-4.05
Free Cash Flow per Basic Share
-4.5
-21.99
-8.06
-28.25
-5.48
-7.31
-2.88
-8.6
-10.88
-3.04
-5.09
-3.48
-2.16
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-27.54
-29.56
-31.65
92.79
89.6
87.29
86.59
10.17
7.85
6.48
-0.4
-3.74
-1.81
Tangible Book Value per Share
34.12
143.39
132.82
218.27
211.97
205.22
205.21
203.08
191.99
183.38
181.36
178.76
176.28
Basic Weighted Avg Shares
174
193
203
214
215
215
215
215
215
215
211
211
216
Sales/Revenue/Turnover
456
631
1,265
1,660
1,728
1,709
1,792
1,875
2,150
3,289
4,354
4,384
2,250
Operating Margin (%)
-252.92
-279.77
-102.15
-42.05
-38.19
-48.57
-57.92
-37.33
-40.88
-34.84
-46.35
-21.12
-31.2
Depreciation Expense
180
202
280
335
399
436
492
463
482
627
677
592
353
Net Income, GAAP
-688
-916
-718
-676
-673
-632
-152
-59
-498
-298
-1,476
-577
-874
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
263.74
117.4
- -
841.51
- -
- -
- -
Profit Margin (%)
-150.79
-145.09
-56.77
-40.72
-38.95
-36.98
-8.48
-3.15
-23.16
-9.06
-33.9
-13.16
-38.84
Working Capital
4,791
42,951
20,728
33,838
31,148
29,973
29,081
26,585
22,037
17,856
17,233
15,673
16,065
LT Debt
- -
19,884
- -
- -
- -
- -
364
329
423
433
388
266
303
Total Equity
5,996
27,777
27,064
46,737
45,674
44,203
44,259
43,786
43,450
41,983
40,477
39,593
40,067
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
3.82
0.27
- -
19.61
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
-1.68
-0.44
- -
-77.01
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
-3.44
-3.32
-0.81
-0.57
-25.7
-19.35
- -
- -
-329.85

Capital Structure

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
ST Debt
244
- -
233
LT Borrowings
22
- -
20
LT Finance Leases
366
- -
283
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
211
- -
211
Market Capitalization
44,445
41,629
38,732

Working Capital

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
Total Current Assets
18,469
- -
17,233
Cash, Cash Equivalents & STI
16,659
- -
15,630
Accounts Receivable, Net
674
- -
515
Inventories
997
- -
881
Total Current Liabilities
1,236
- -
1,168
Payables & Accruals
- -
- -
- -
ST Debt
244
- -
233
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.38%
-2.2%
-2.18%
Free Cash Flow
28.54%
37.18%
-31.56%
Net Income, GAAP
86.72%
195.42%
-60.91%
Sales/Revenue/Turnover
24.48%
21.07%
0.69%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,045
1,058
1,115
1,135
4,354
2025
- -
- -
- -
- -
4,384
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.56
-4.42
-1.65
- -
-6.99
2025
- -
- -
- -
- -
-2.73
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Yoshiyuki Sankai
Full Time Employees
227
Sector
Healthcare
Industry
Medical - Devices
Address
2-2-1, Gakuen-Minami Tsukuba Japan 305-0818
IPO Date
Oct 2, 2017
Website
cyberdyne.jp
Similar Companies
Bluelinea S.A. (ALBLU.PA)
Nuwellis, Inc. (NUWE)
Erika Carmel-Tech Ltd (ERKA.TA)
Aziyo Biologics, Inc. (AZYO)
MicroTech Medical (Hangzhou) Co., Ltd. (2235.HK)
Imricor Medical Systems, Inc. (IMR.AX)
Business
CYBERDYNE Inc. is a Japanese technology company specializing in the development, manufacturing, and sales of robotic exoskeletons and related medical and welfare support devices. Its core products include the HAL (Hybrid Assistive Limb) robotic exoskeleton for medical rehabilitation and cybernic treatment; robotic systems for support in nursing care and physical labor; and service offerings including robot-based therapy and healthcare support solutions. The company operates primarily in Japan, with expanding commercial and medical applications in global markets. Founded in 2004 and headquartered in Tsukuba, Ibaraki Prefecture, Japan, CYBERDYNE aims to enhance mobility and quality of life through innovation in robotics and medical device technology. In the last two years, CYBERDYNE has focused on strategic expansion of its product lineup and market reach. The company has launched new versions of its HAL exoskeleton targeting broader rehabilitation applications and elder care. It formed significant partnerships with healthcare institutions and local governments to promote robotic support services in elderly care and community rehabilitation programs. CYBERDYNE also expanded its operational presence beyond Japan, seeking to commercialize its technologies internationally. Notably, the company is advancing research collaborations and enhancing production capabilities to address rising demand in medical robotics and welfare sectors. CYBERDYNE operates within the healthcare technology and robotics industry segments, serving hospitals, rehabilitation centers, nursing care providers, and industrial clients requiring support in physical labor tasks. Its customer base ranges from individual patients needing mobility assistance to government and private sector entities implementing robotic welfare support infrastructure. The company is publicly traded under the ticker CYBQF and continues to invest in R&D, product innovation, and strategic business development to maintain its leadership in the advanced robotics and medical device markets. Its subsidiaries enhance operational capabilities in manufacturing and distribution, aligning with its mission to bring cutting-edge cybernic technologies to users worldwide.

Company News

APIChat